Literature DB >> 27411908

Deregulation and therapeutic potential of microRNAs in arthritic diseases.

Rita Vicente, Danièle Noël, Yves-Marie Pers, Florence Apparailly, Christian Jorgensen.   

Abstract

Entities:  

Year:  2016        PMID: 27411908     DOI: 10.1038/nrrheum.2016.119

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

Review 1.  Deregulation and therapeutic potential of microRNAs in arthritic diseases.

Authors:  Rita Vicente; Danièle Noël; Yves-Marie Pers; Florence Apparailly; Christian Jorgensen
Journal:  Nat Rev Rheumatol       Date:  2015-12-24       Impact factor: 20.543

  1 in total
  16 in total

Review 1.  [Role of non-coding regulatory ribonucleic acids in chronic inflammatory diseases].

Authors:  G A Heinz; M-F Mashreghi
Journal:  Z Rheumatol       Date:  2016-05       Impact factor: 1.372

2.  Combination of circulating miR-19b-3p, miR-122-5p and miR-486-5p expressions correlates with risk and disease severity of knee osteoarthritis.

Authors:  Ruina Kong; Jie Gao; Yanhui Si; Dongbao Zhao
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

3.  miR-219 Cooperates with miR-338 in Myelination and Promotes Myelin Repair in the CNS.

Authors:  Haibo Wang; Ana Lis Moyano; Zhangyan Ma; Yaqi Deng; Yifeng Lin; Chuntao Zhao; Liguo Zhang; Minqing Jiang; Xuelian He; Zhixing Ma; Fanghui Lu; Mei Xin; Wenhao Zhou; Sung Ok Yoon; Ernesto R Bongarzone; Q Richard Lu
Journal:  Dev Cell       Date:  2017-03-27       Impact factor: 12.270

4.  SEMA6D, Negatively Regulated by miR-7, Contributes to C28/I2 chondrocyte's Catabolic and Anabolic Activities via p38 Signaling Pathway.

Authors:  Haoyu Yang; Zhicheng Yang; Zhentang Yu; Chenwei Xiong; Yi Zhang; Junjie Zhang; Yong Huang; Xindie Zhou; Jin Li; Nanwei Xu
Journal:  Oxid Med Cell Longev       Date:  2022-06-16       Impact factor: 7.310

5.  Expression of miR-146a, miR-155, and miR-223 in formalin-fixed paraffin-embedded synovial tissues of patients with rheumatoid arthritis and osteoarthritis.

Authors:  Mark Kriegsmann; Thomas M Randau; Sascha Gravius; Katharina Lisenko; Carolin Altmann; Norbert Arens; Jörg Kriegsmann
Journal:  Virchows Arch       Date:  2016-04-14       Impact factor: 4.064

6.  Myostatin Promotes Interleukin-1β Expression in Rheumatoid Arthritis Synovial Fibroblasts through Inhibition of miR-21-5p.

Authors:  Sung-Lin Hu; An-Chen Chang; Chien-Chung Huang; Chun-Hao Tsai; Cheng-Chieh Lin; Chih-Hsin Tang
Journal:  Front Immunol       Date:  2017-12-08       Impact factor: 7.561

7.  Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy.

Authors:  Hani Choudhry; Mazin A Zamzami; Ziad Omran; Wei Wu; Marc Mousli; Christian Bronner; Mahmoud Alhosin
Journal:  Oncol Lett       Date:  2017-10-30       Impact factor: 2.967

Review 8.  The Emerging Role of Epigenetics in Autoimmune Thyroid Diseases.

Authors:  Bin Wang; Xiaoqing Shao; Ronghua Song; Donghua Xu; Jin-An Zhang
Journal:  Front Immunol       Date:  2017-04-07       Impact factor: 7.561

9.  Identification of new biomarkers to promote personalised treatment of patients with inflammatory rheumatic disease: protocol for an open cohort study.

Authors:  Tina Marie Kringelbach; Bente Glintborg; Estrid V Hogdall; Julia Sidenius Johansen; Merete Lund Hetland
Journal:  BMJ Open       Date:  2018-02-01       Impact factor: 2.692

10.  The hsa-miR-181a-5p reduces oxidation resistance by controlling SECISBP2 in osteoarthritis.

Authors:  Jianli Xue; Zixin Min; Zhuqing Xia; Bin Cheng; Binshang Lan; Fujun Zhang; Yan Han; Kunzheng Wang; Jian Sun
Journal:  BMC Musculoskelet Disord       Date:  2018-10-05       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.